Freedom Biosciences develops a biotechnology platform focused on next-generation psychedelic therapeutics. The company advances ketamine-based therapies and combines neuropsychiatric drugs to create treatments for mental health and substance use disorders, including depression and PTSD, with the aim of offering more effective and safer options for patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.